Clinical trial

Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes

NCT00715663

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention biphasic insulin aspart 30 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2007-02-01

PhaseN/A

Conditions

Diabetesverified · MONDO: diabetes mellitus

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Delivery Systemsunresolved

Interventions

biphasic insulin aspart 30DRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00715663 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.